Cargando…

Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative Stress, and Cisplatin-Induced Nephrotoxicity

Although epoxyeicosatrienoic acid (EET) analogs have performed well in several acute and chronic kidney disease models, targeted delivery of EET analogs to the kidney can be reasonably expected to reduce the level of drug needed to achieve a therapeutic effect and obviate possible side effects. For...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imig, John D., Hye Khan, Md Abdul, Burkhan, Anna, Chen, Guan, Adebesin, Adeniyi Michael, Falck, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998941/ https://www.ncbi.nlm.nih.gov/pubmed/33801911 http://dx.doi.org/10.3390/ijms22062793

Ejemplares similares

Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
por: Hye Khan, Md. Abdul, et al.
Publicado: (2019)

Epoxyeicosatrienoic acid analog EET-B attenuates post-myocardial infarction remodeling in spontaneously hypertensive rats
por: Neckář, Jan, et al.
Publicado: (2019)

Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats
por: Walkowska, Agnieszka, et al.
Publicado: (2021)

Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
por: Hye Khan, Md. Abdul, et al.
Publicado: (2014)

Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats
por: Baranowska, Iwona, et al.
Publicado: (2022)

Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
por: Skibba, Melissa, et al.
Publicado: (2017)

Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs)
por: Lee, Alison R., et al.
Publicado: (2013)

Development of Epoxyeicosatrienoic Acid Analogs with in Vivo Anti-Hypertensive Actions
por: Imig, John D., et al.
Publicado: (2010)

14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014)

Correction to 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates: Carboxylate Modifications
por: Falck, John R., et al.
Publicado: (2014)

PPARγ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPS
por: Samokhvalov, Victor, et al.
Publicado: (2014)

The Contribution of Arachidonic Acid Metabolites EETs to Inflammation in Obesity
por: Mashayekhi, Mona, et al.
Publicado: (2021)

Erratum on: Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury
Publicado: (2014)

Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats
por: Hrdlička, Jaroslav, et al.
Publicado: (2019)

Mechanisms of Cisplatin Nephrotoxicity
por: Miller, Ronald P., et al.
Publicado: (2010)

Prevention of cisplatin nephrotoxicity
por: Hayati, Fatemeh, et al.
Publicado: (2015)

A Synthetic Epoxydocosapentaenoic Acid Analogue Ameliorates Cardiac Ischemia/Reperfusion Injury: The Involvement of the Sirtuin 3–NLRP3 Pathway
por: Darwesh, Ahmed M., et al.
Publicado: (2020)

“NETs and EETs, a Whole Web of Mess”
por: Williams, Tyler L., et al.
Publicado: (2020)

F2-layer height of the peak electron density (hmF2) dataset employed in Inferring Vertical Plasma Drift – Data of Best fit
por: Adebesin, B.O., et al.
Publicado: (2018)

Effects of Epoxyeicosatrienoic Acid-Enhancing Therapy on the Course of Congestive Heart Failure in Angiotensin II-Dependent Rat Hypertension: From mRNA Analysis towards Functional In Vivo Evaluation
por: Kala, Petr, et al.
Publicado: (2021)

Downregulation of PGC-1α Prevents the Beneficial Effect of EET-Heme Oxygenase-1 on Mitochondrial Integrity and Associated Metabolic Function in Obese Mice
por: Singh, Shailendra P., et al.
Publicado: (2016)

Anti-Inflammatory Effects of Epoxyeicosatrienoic Acids
por: Thomson, Scott J., et al.
Publicado: (2012)

The role of epoxyeicosatrienoic acids in the cardiovascular system
por: Yang, L, et al.
Publicado: (2015)

Inside epoxyeicosatrienoic acids and cardiovascular disease
por: Tacconelli, Stefania, et al.
Publicado: (2014)

The Role of Epoxyeicosatrienoic Acids in Cardiac Remodeling
por: Lai, Jinsheng, et al.
Publicado: (2021)

Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response
por: Samokhvalov, V, et al.
Publicado: (2013)

Epoxyeicosatrienoic Acids and Fibrosis: Recent Insights for the Novel Therapeutic Strategies
por: Guan, Xin-Xin, et al.
Publicado: (2021)

Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen
por: Huang, An, et al.
Publicado: (2018)

Amelioration of cisplatin-induced nephrotoxicity by statins
por: Maheshwari, Rajesh A., et al.
Publicado: (2013)

Regio- and Enantioselective Catalytic Monoepoxidation of Conjugated Dienes: Synthesis of Chiral Allylic cis-Epoxides
por: Jat, Jawahar L., et al.
Publicado: (2015)

2nd International Conference on Education and Educational Technology (EET 2011)
por: Wang, Yuanzhi
Publicado: (2012)

2nd International Conference on Education and Educational Technology (EET 2011)
por: Wang, Yuanzhi
Publicado: (2012)

20-HETE and EETs in Diabetic Nephropathy: A Novel Mechanistic Pathway
por: Eid, Stephanie, et al.
Publicado: (2013)

Theoretical model for neurovascular coupling via interactions of NO, EET, and 20-HETE
por: Kang, Hyuk, et al.
Publicado: (2013)

Effect of infliximab against cisplatin-induced nephrotoxicity
por: Cure, Erkan, et al.
Publicado: (2014)

Renoprotective effects of antioxidants against cisplatin nephrotoxicity
por: Hajian, Shabnam, et al.
Publicado: (2014)

Cisplatin therapy and the problem of gender-related nephrotoxicity
por: Nasri, Hamid
Publicado: (2013)

Aging increases the susceptibility of cisplatin-induced nephrotoxicity
por: Wen, Jiagen, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Time course of cisplatin-induced nephrotoxicity and hepatotoxicity
por: Pezeshki, Zahra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mlvt73dhbum9oqa1uog60amdum